Osaühing Berlin-Chemie Menarini Eesti
- Registry code
- 11100035
- VAT number
- EE100949993
- Address
- Harju maakond, Tallinn, Kristiine linnaosa, Paldiski mnt 29, 10612
- Registered
- 31.01.2005 · 21 yrs
- Activity
- Wholesale of pharmaceutical goods 46461
- Capital
- 22 369 €
- e•••@b•••.comLog in to see
- Phone
- +372 •• ••••Log in to see
- Website
- www.berlin-chemie.com
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2025)
- VAT registered
Add the rating badge to your website
The badge code is available to this company's verified account: verification uses a code we send to the company email in the Business Register. The badge updates itself and cannot be bought. Read more
Board and owners
3 persons
| Board 2 | ||
|---|---|---|
| Edita Grinyte1 companyno tax debt | Personal ID ↗ | 23.04.2015 |
| Petras Letauta1 companyno tax debt | Personal ID ↗ | 30.05.2022 |
| Other persons 1 | ||
| Kristi Reimann2 companiesno tax debtProcurator | Personal ID ↗ | 15.11.2018 |
| Shareholders 1 | ||
| Aktsiaselts BERLIN CHEMIE MENARINI BALTIC | 100,0% 22 369 € | 01.09.2023 |
| Beneficial owners 1 | ||
| Massimiliana Landinidirect holding | 27.09.2018 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
2026 Q2. Wage is estimated from employment taxes.
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 8 064 392 € | ▲ 1% | 352 268 € | 633 740 € | 27 |
| 2026 Q1 | 8 522 981 € | ▲ 14% | 212 680 € | 536 338 € | 27 |
| 2025 Q4 | 7 818 127 € | ▲ 1% | 223 957 € | 510 981 € | 27 |
| 2025 Q3 | 7 828 932 € | ▲ 15% | 203 747 € | 615 930 € | 27 |
| 2025 Q2 | 7 960 899 € | ▲ 8% | 363 906 € | 624 337 € | 27 |
| 2025 Q1 | 7 445 168 € | ▼ 2% | 211 579 € | 516 855 € | 27 |
| 2024 Q4 | 7 709 836 € | ▼ 1% | 198 082 € | 625 362 € | 26 |
| 2024 Q3 | 6 793 121 € | ▼ 0% | 215 357 € | 969 104 € | 26 |
| 2024 Q2 | 7 360 981 € | ▲ 8% | 300 348 € | 643 362 € | 27 |
| 2024 Q1 | 7 577 389 € | ▲ 14% | 178 362 € | 493 556 € | 26 |
| 2023 Q4 | 7 801 369 € | ▲ 9% | 178 156 € | 468 382 € | 24 |
| 2023 Q3 | 6 804 071 € | ▲ 13% | 153 111 € | 677 935 € | 25 |
Show full history (18 quarters)
| 2023 Q2 | 6 790 616 € | ▲ 6% | 286 183 € | 565 311 € | 24 |
| 2023 Q1 | 6 644 894 € | ▲ 9% | 169 817 € | 434 333 € | 26 |
| 2022 Q4 | 7 170 126 € | 159 942 € | 459 343 € | 25 | |
| 2022 Q3 | 6 047 950 € | 138 208 € | 386 756 € | 25 | |
| 2022 Q2 | 6 384 608 € | 252 301 € | 496 279 € | 24 | |
| 2022 Q1 | 6 074 168 € | 156 670 € | 380 564 € | 27 |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
5 yr
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Sales revenue | 17,3 m € | ▲ 4% | 16,6 m € | ▲ 9% | 15,3 m € | ▲ 11% | 13,8 m € | ▲ 7% | 12,9 m € |
| Profit | 515 k € | ▲ 638% | 69 820 € | ▼ 88% | 600 k € | ▼ 11% | 676 k € | ▼ 28% | 945 k € |
| Profit margin | 3,0% | 0,4% | 3,9% | 4,9% | 7,3% | ||||
| Retained earnings | 3,1 m € | ▼ 11% | 3,5 m € | ▼ 41% | 5,9 m € | ▼ 5% | 6,2 m € | ▲ 18% | 5,3 m € |
| Cash | 5 077 € | ▼ 98% | 204 k € | ▼ 78% | 942 k € | ▲ 2% | 920 k € | ▲ 89% | 486 k € |
| Current assets | 6,2 m € | ▲ 22% | 5,1 m € | ▼ 31% | 7,3 m € | ▼ 18% | 8,9 m € | ▲ 5% | 8,5 m € |
| Fixed assets | 102 k € | ▲ 29% | 78 886 € | ▲ 92% | 41 148 € | ▲ 35% | 30 530 € | ▲ 45% | 21 119 € |
| Assets | 6,3 m € | ▲ 22% | 5,1 m € | ▼ 30% | 7,3 m € | ▼ 17% | 8,9 m € | ▲ 5% | 8,5 m € |
| Current liabilities | 2,6 m € | ▲ 70% | 1,5 m € | ▲ 90% | 809 k € | ▼ 59% | 2,0 m € | ▼ 11% | 2,2 m € |
| Total liabilities | 2,6 m € | ▲ 70% | 1,5 m € | ▲ 90% | 809 k € | ▼ 59% | 2,0 m € | ▼ 11% | 2,2 m € |
| Equity | 3,7 m € | ▲ 2% | 3,6 m € | ▼ 45% | 6,5 m € | ▼ 6% | 6,9 m € | ▲ 11% | 6,3 m € |
| Labour costs | 2,2 m € | ▲ 7% | 2,1 m € | ▲ 11% | 1,9 m € | ▲ 12% | 1,7 m € | ▲ 4% | 1,6 m € |
| Employees | 27 | ▲ 4% | 26 | ▲ 4% | 25 | 0% | 25 | ▼ 7% | 27 |
| Filed | 12.06.2026 | 13.06.2025 | 17.05.2024 | 25.05.2023 | 06.05.2022 | ||||
| Report | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ |
▲ growth, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2025
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Wholesale of pharmaceutical goods main activity | 46461 | 17 304 741 € | 100% |
2025 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
none
No transactions with state agencies, procurement contracts or grants found
RTK Saldo, Riigihangete register, RTK toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
1
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Wholesale of pharmaceutical goods
20
| # | Company | Revenue |
|---|---|---|
| 1 | MAGNUM MEDICAL OÜ | 295,0 m € |
| 2 | TAMRO EESTI OÜ | 239,6 m € |
| 3 | Novo Nordisk Estonia OÜ | 37,0 m € |
| 4 | SONA-PHARM OÜ | 36,9 m € |
| 5 | Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal | 30,7 m € |
| 6 | Aktsiaselts Magnum Veterinaaria | 28,6 m € |
| 7 | Osaühing Zoovetvaru | 21,5 m € |
| 8 | Osaühing Berlin-Chemie Menarini Eesti | 17,3 m € |
| 9 | Globalex Pharma OÜ | 16,1 m € |
| 10 | OÜ Micotrade | 15,8 m € |
| 11 | Apteegikaubanduse Hulgimüük OÜ | 12,2 m € |
| 12 | Aktsiaselts FORANS EESTI | 8,0 m € |
| 13 | DAAAK Pharma Int. AS | 7,6 m € |
| 14 | Gerdavit OÜ | 7,2 m € |
| 15 | AS Oribalt Tallinn | 7,0 m € |
| 16 | Aktsiaselts PAIRA | 6,2 m € |
| 17 | ORNYX OÜ | 5,1 m € |
| 18 | Pharm Origin OÜ | 5,1 m € |
| 19 | First Pharma OÜ | 4,9 m € |
| 20 | Hiirehernes OÜ | 4,8 m € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Domains
1 records
Domains
| Domain | Source |
|---|---|
| berlin-chemie.com | Business Register |
History and notices
10
| Date | Type | Content |
|---|---|---|
| 01.09.2023 | Entry | Amendment entry |
| 30.05.2022 | Entry | Amendment entry |
| 15.11.2018 | Entry | Amendment entry |
| 20.07.2018 | Entry | Amendment entry |
| 17.01.2018 | Entry | Amendment entry |
| 23.04.2015 | Entry | Amendment entry |
| 09.06.2011 | Entry | Amendment entry |
| 03.12.2008 | Tegevusalade kustutamine registrikaardilt | Amendment entry |
| 31.01.2005 | Jaatav kandeotsus | First entry |
| 12.01.2005 | Kättetoimetatav puuduste kõrvaldamise määrus | First entry |